| Insideraktier | 1.234.255 shares |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Netto antal insidere, der køber (rang)
N/A
Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).
Procent af float købt af insidere (rangering)
N/A
Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.
Insiderhandelsdiagram
Harpoon Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i HARP / Harpoon Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i HARP / Harpoon Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-11 | 2024-03-11 | 4 | New Leaf Biopharma Opportunities II, L.P. | HARP | 8.000% Series A Redeemable Preferred Stock | D | -10.000 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | New Leaf Biopharma Opportunities II, L.P. | HARP | Common Stock | I | -395.783 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | New Leaf Biopharma Opportunities II, L.P. | HARP | Common Stock | D | -1.463.386 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | Walker Luke Nathaniel | HARP | Common Stock | D | -135.000 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | SILVERNAIL LAUREN P | HARP | Common Stock | D | -5.000 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | HUNT RONALD | HARP | 8.000% Series A Redeemable Preferred Stock | I | -10.000 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | HUNT RONALD | HARP | Common Stock | I | -395.783 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | HUNT RONALD | HARP | Common Stock | I | -1.463.386 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | HUNT RONALD | HARP | Common Stock | D | -13.224 | 0 | ||||||
| 2024-03-11 | 2024-03-08 | 4 | HUNT RONALD | HARP | Common Stock | D | 424 | 13.224 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | Myers Scott Dunseth | HARP | Common Stock | D | -22.665 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | Chin Mark | HARP | Common Stock | D | -13.224 | 0 | ||||||
| 2024-03-11 | 2024-03-08 | 4 | Chin Mark | HARP | Common Stock | D | 424 | 13.224 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | DRACHMAN JONATHAN G | HARP | Common Stock | D | -5.415 | 0 | ||||||
| 2024-03-11 | 2024-03-08 | 4 | DRACHMAN JONATHAN G | HARP | Common Stock | D | 415 | 5.415 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | Robbins Andrew R | HARP | Common Stock | D | -5.000 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | BAILES JOSEPH S | HARP | Common Stock | D | -5.000 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | EASTLAND JULIA MARIE | HARP | Common Stock | D | -269.381 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | EASTLAND JULIA MARIE | HARP | Common Stock | D | 31.250 | 269.381 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | Lanza Frank J | HARP | Common Stock | D | -18.734 | 0 | ||||||
| 2024-03-11 | 2024-03-11 | 4 | Merck & Co., Inc. | HARP | Common Stock, par value $0.0001 | I | 23,0000 | 21.397.205 | 492.136 | 1.000 | ||||
| 2024-01-17 | 3 | Merck & Co., Inc. See Footnotes | HARP | Common Stock, par value $0.0001 | I | 0 | ||||||||
| 2024-01-09 | 2024-01-07 | 4 | Lanza Frank J | HARP | Common Stock | D | 15.000 | 18.362 | ||||||
| 2024-01-09 | 2024-01-07 | 4 | EASTLAND JULIA MARIE | HARP | Common Stock | D | 178.500 | 232.003 | ||||||
| 2024-01-09 | 2024-01-07 | 4 | Walker Luke Nathaniel | HARP | Common Stock | D | 115.000 | 135.000 | ||||||
| 2024-01-03 | 2024-01-01 | 4 | Chin Mark | HARP | Common Stock | D | 1.072 | 12.801 | ||||||
| 2024-01-03 | 2024-01-01 | 4 | HUNT RONALD | HARP | Common Stock | D | 1.072 | 12.801 | ||||||
| 2024-01-03 | 2024-01-01 | 4 | Myers Scott Dunseth | HARP | Common Stock | D | 2.048 | 22.666 | ||||||
| 2023-11-28 | 2023-11-26 | 4 | Walker Luke Nathaniel | HARP | Common Stock | D | 20.000 | 20.000 | ||||||
| 2023-11-28 | 2023-11-26 | 4 | Lanza Frank J | HARP | Common Stock | D | 2.000 | 3.362 | ||||||
| 2023-11-28 | 2023-11-26 | 4 | EASTLAND JULIA MARIE | HARP | Common Stock | D | 50.000 | 53.503 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | SILVERNAIL LAUREN P | HARP | Common Stock | D | 5.000 | 5.000 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | Robbins Andrew R | HARP | Common Stock | D | 5.000 | 5.000 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | Myers Scott Dunseth | HARP | Common Stock | D | 5.000 | 20.618 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | HUNT RONALD | HARP | Common Stock | D | 5.000 | 11.729 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | Chin Mark | HARP | Common Stock | D | 5.000 | 11.729 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | DRACHMAN JONATHAN G | HARP | Common Stock | D | 5.000 | 5.000 | ||||||
| 2023-11-28 | 2023-11-27 | 4 | BAILES JOSEPH S | HARP | Common Stock | D | 5.000 | 5.000 | ||||||
| 2023-10-27 | 2023-10-25 | 4 | New Leaf Biopharma Opportunities II, L.P. | HARP | Common Stock | I | 171.500 | 395.783 | ||||||
| 2023-10-27 | 2023-10-25 | 4 | New Leaf Biopharma Opportunities II, L.P. | HARP | Common Stock | D | 1.372.000 | 1.463.386 | ||||||
| 2023-10-27 | 2023-10-25 | 4 | HUNT RONALD | HARP | Common Stock | I | 171.500 | 395.783 | ||||||
| 2023-10-27 | 2023-10-25 | 4 | HUNT RONALD | HARP | Common Stock | I | 1.372.000 | 1.463.386 | ||||||
| 2023-10-02 | 2023-10-01 | 4 | Myers Scott Dunseth | HARP | Common Stock | D | 5.797 | 15.618 | ||||||
| 2023-10-02 | 2023-10-01 | 4 | HUNT RONALD | HARP | Common Stock | D | 3.035 | 6.729 | ||||||
| 2023-10-02 | 2023-10-01 | 4 | Chin Mark | HARP | Common Stock | D | 3.035 | 6.729 | ||||||
| 2023-07-06 | 2023-07-01 | 4 | Myers Scott Dunseth | HARP | Common Stock | D | 35.634 | 98.215 | ||||||
| 2023-07-06 | 2023-07-01 | 4 | Chin Mark | HARP | Common Stock | D | 18.656 | 36.941 | ||||||
| 2023-07-06 | 2023-07-01 | 4 | HUNT RONALD | HARP | Common Stock | D | 18.656 | 36.941 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | Colowick Alan | HARP | Common Stock | D | 16.456 | 16.456 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | Myers Scott Dunseth | HARP | Common Stock | D | 34.925 | 62.581 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | HUNT RONALD | HARP | Common Stock | D | 18.285 | 18.285 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | Chin Mark | HARP | Common Stock | D | 18.285 | 18.285 | ||||||
| 2023-04-04 | 2023-04-01 | 4 | Viney Joanne L. | HARP | Common Stock | D | 21.028 | 21.028 | ||||||
| 2023-03-27 | 3 | Lathi Vijay K See footnotes | HARP | Common Stock | I | 2.242.839 | ||||||||
| 2023-03-27 | 3 | Lathi Vijay K | HARP | Common Stock | D | 913.860 | ||||||||
| 2023-03-27 | 3 | Lathi Vijay K | HARP | 8.000% Series A Redeemable Preferred Stock | D | 10.000 | ||||||||
| 2023-03-27 | 2023-03-23 | 4 | HUNT RONALD | HARP | 8.000% Series A Redeemable Preferred Stock | I | 1.000,0000 | 10.000 | 10.000 | 10.000 | ||||
| 2022-10-04 | 3 | Walker Luke Nathaniel | HARP | No securities are beneficially owned | D | 0 | ||||||||
| 2022-09-19 | 3 | Lanza Frank J | HARP | Common Stock | D | 6.540 | ||||||||
| 2022-09-19 | 3 | SILVERNAIL LAUREN P | HARP | No securities are beneficially owned | D | 0 | ||||||||
| 2022-02-01 | 2022-01-28 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 5,03 | 135.000 | 135.000 | |||||
| 2022-02-01 | 2022-01-28 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 5,03 | 155.000 | 155.000 | |||||
| 2022-02-01 | 2022-01-28 | 4 | Erbez Georgia | HARP | Employee Stock Option (right to buy) | D | 5,03 | 115.000 | 115.000 | |||||
| 2021-11-15 | 2021-11-11 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 7,73 | 135.000 | 135.000 | |||||
| 2021-11-15 | 2021-11-11 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 7,73 | 155.000 | 155.000 | |||||
| 2021-11-15 | 2021-11-11 | 4 | Erbez Georgia | HARP | Employee Stock Option (right to buy) | D | 7,73 | 115.000 | 115.000 | |||||
| 2021-11-09 | 2021-11-08 | 4 | EASTLAND JULIA MARIE | HARP | Stock Option (Right to Buy) | D | 6,85 | 350.000 | 350.000 | |||||
| 2021-10-26 | 2021-10-25 | 4 | Myers Scott Dunseth | HARP | Director Stock Option (Right to Buy) | D | 6,31 | 10.167 | 10.167 | |||||
| 2021-09-22 | 2021-09-22 | 4 | Erbez Georgia By IRA | HARP | Common Stock | I | 8,1000 | 10.300 | 83 | 19.215 | ||||
| 2021-08-12 | 2021-01-11 | 4 | New Leaf Ventures III, L.P. | HARP | Common Stock | I | 17,0000 | 235.294 | 4.000 | 913.860 | ||||
| 2021-08-12 | 2021-01-11 | 4 | HUNT RONALD | HARP | Common Stock | I | 17,0000 | 235.294 | 4.000 | 913.860 | ||||
| 2021-07-06 | 2021-07-01 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | -10.000 | 21.002 | |||||
| 2021-07-06 | 2021-07-01 | 4 | Wesche Holger | HARP | Common Stock | D | 14,0000 | -10.000 | -140 | 52.852 | ||||
| 2021-07-06 | 2021-07-01 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 10.000 | 6 | 62.852 | ||||
| 2021-06-02 | 2021-06-02 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,5000 | -25.118 | -515 | 6.328.095 | ||||
| 2021-06-02 | 2021-06-01 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,4400 | -18.491 | -378 | 6.353.213 | ||||
| 2021-06-02 | 2021-05-28 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22,6000 | -100 | -2 | 6.371.704 | ||||
| 2021-06-02 | 2021-05-28 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 21,9200 | -3.100 | -68 | 6.371.804 | ||||
| 2021-06-02 | 2021-05-28 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,8800 | -10.685 | -223 | 6.374.904 | ||||
| 2021-05-27 | 2021-05-27 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,2600 | -13.961 | -283 | 6.385.589 | ||||
| 2021-05-27 | 2021-05-26 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,0400 | -3.198 | -64 | 6.399.550 | ||||
| 2021-05-24 | 2021-05-24 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,1200 | -5.000 | -101 | 6.402.748 | ||||
| 2021-05-24 | 2021-05-21 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,2100 | -10.907 | -220 | 6.407.748 | ||||
| 2021-05-20 | 2021-05-20 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,3400 | -11.713 | -238 | 6.418.655 | ||||
| 2021-05-20 | 2021-05-19 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,3900 | -17.833 | -364 | 6.430.368 | ||||
| 2021-05-20 | 2021-05-18 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,6700 | -18.402 | -380 | 6.448.201 | ||||
| 2021-05-17 | 2021-05-17 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,0700 | -4.666 | -94 | 6.466.603 | ||||
| 2021-05-17 | 2021-05-14 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,0400 | -6.900 | -138 | 6.471.269 | ||||
| 2021-05-17 | 2021-05-13 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,0600 | -4.855 | -97 | 6.478.169 | ||||
| 2021-05-14 | 2021-05-04 | 4/A | Viney Joanne L. | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 2.571 | 2.571 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | Viney Joanne L. | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 10.167 | 10.167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | BAILES JOSEPH S | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 10.167 | 10.167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | Robbins Andrew R | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 10.167 | 10.167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | Myers Scott Dunseth | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 10.167 | 10.167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | EASTLAND JULIA MARIE | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 10.167 | 10.167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 4.658 | 4.658 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 10.167 | 10.167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | DRACHMAN JONATHAN G | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 10.167 | 10.167 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 2.438 | 2.438 | |||||
| 2021-05-14 | 2021-05-04 | 4/A | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 23,20 | 10.167 | 10.167 | |||||
| 2021-05-12 | 2021-05-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,5300 | -29.684 | -609 | 6.483.024 | ||||
| 2021-05-12 | 2021-05-11 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 21,5100 | -7.672 | -165 | 6.512.708 | ||||
| 2021-05-12 | 2021-05-11 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,9600 | -13.773 | -289 | 6.520.380 | ||||
| 2021-05-12 | 2021-05-10 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22,4600 | -411 | -9 | 6.534.153 | ||||
| 2021-05-12 | 2021-05-10 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 21,7800 | -16.722 | -364 | 6.534.564 | ||||
| 2021-05-07 | 2021-05-04 | 4 | Colowick Alan | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 10.167 | 10.167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | Viney Joanne L. | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 2.653 | 2.653 | |||||
| 2021-05-07 | 2021-05-04 | 4 | Viney Joanne L. | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 10.167 | 10.167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | BAILES JOSEPH S | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 10.167 | 10.167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | Myers Scott Dunseth | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 10.167 | 10.167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | Robbins Andrew R | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 10.167 | 10.167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | EASTLAND JULIA MARIE | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 10.167 | 10.167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 4.807 | 4.807 | |||||
| 2021-05-07 | 2021-05-04 | 4 | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 10.167 | 10.167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | DRACHMAN JONATHAN G | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 10.167 | 10.167 | |||||
| 2021-05-07 | 2021-05-04 | 4 | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 3.017 | 3.017 | |||||
| 2021-05-07 | 2021-05-04 | 4 | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 22,50 | 10.167 | 10.167 | |||||
| 2021-05-06 | 2021-05-05 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 23,0900 | -59 | -1 | 6.551.286 | ||||
| 2021-05-06 | 2021-05-05 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22,5200 | -10.113 | -228 | 6.551.345 | ||||
| 2021-05-04 | 2021-05-04 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 23,3300 | -3.500 | -82 | 6.561.458 | ||||
| 2021-05-04 | 2021-05-04 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 23,0300 | -26.230 | -604 | 6.564.958 | ||||
| 2021-05-04 | 2021-05-03 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 23,4500 | -4.401 | -103 | 6.591.188 | ||||
| 2021-05-04 | 2021-05-03 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 23,0300 | -26.365 | -607 | 6.595.589 | ||||
| 2021-05-04 | 2021-04-30 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22,3500 | -268.023 | -5.990 | 6.621.954 | ||||
| 2021-04-29 | 2021-04-29 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22,5400 | -21.781 | -491 | 6.889.977 | ||||
| 2021-04-29 | 2021-04-29 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22,0200 | -45.511 | -1.002 | 6.911.758 | ||||
| 2021-04-29 | 2021-04-28 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22,0100 | -36.803 | -810 | 6.957.269 | ||||
| 2021-04-29 | 2021-04-28 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 21,6400 | -14.219 | -308 | 6.994.072 | ||||
| 2021-04-29 | 2021-04-27 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 21,2600 | -8.328 | -177 | 7.008.291 | ||||
| 2021-04-29 | 2021-04-27 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,9900 | -3.501 | -73 | 7.016.619 | ||||
| 2021-04-22 | 2021-04-21 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 19,4800 | -555 | -11 | 7.020.120 | ||||
| 2021-04-22 | 2021-04-21 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 18,9400 | -8.417 | -159 | 7.020.675 | ||||
| 2021-04-20 | 2021-04-20 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 19,0900 | -834 | -16 | 7.029.092 | ||||
| 2021-04-20 | 2021-04-20 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 18,7000 | -21.415 | -400 | 7.029.926 | ||||
| 2021-04-20 | 2021-04-19 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,0800 | -100 | -2 | 7.051.341 | ||||
| 2021-04-20 | 2021-04-19 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 19,2900 | -9.956 | -192 | 7.051.441 | ||||
| 2021-04-20 | 2021-04-16 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,5600 | -300 | -6 | 7.061.397 | ||||
| 2021-04-20 | 2021-04-16 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 19,8200 | -5.547 | -110 | 7.061.697 | ||||
| 2021-04-15 | 2021-04-15 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,4900 | -1.052 | -22 | 3.220.844 | ||||
| 2021-04-15 | 2021-04-14 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,8300 | -1.550 | -32 | 3.221.896 | ||||
| 2021-04-15 | 2021-04-14 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,0600 | -121 | -2 | 3.223.446 | ||||
| 2021-04-15 | 2021-04-13 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,0800 | -286 | -6 | 3.223.567 | ||||
| 2021-04-15 | 2021-04-13 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 19,3500 | -1.657 | -32 | 3.223.853 | ||||
| 2021-04-15 | 2021-04-15 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,4900 | -8.696 | -178 | 7.067.244 | ||||
| 2021-04-15 | 2021-04-14 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,8300 | -12.806 | -267 | 7.075.940 | ||||
| 2021-04-15 | 2021-04-14 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,0600 | -1.000 | -20 | 7.088.746 | ||||
| 2021-04-15 | 2021-04-13 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,0800 | -2.362 | -47 | 7.089.746 | ||||
| 2021-04-15 | 2021-04-13 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 19,3500 | -13.692 | -265 | 7.092.108 | ||||
| 2021-04-13 | 2021-04-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 22,6800 | -400 | -9 | 7.105.800 | ||||
| 2021-04-13 | 2021-04-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 21,5200 | -6.700 | -144 | 7.106.200 | ||||
| 2021-04-13 | 2021-04-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 20,7200 | -13.528 | -280 | 7.112.900 | ||||
| 2021-04-13 | 2021-04-09 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 23,6700 | -10.300 | -244 | 7.126.428 | ||||
| 2021-04-13 | 2021-04-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 22,6800 | -48 | -1 | 3.225.510 | ||||
| 2021-04-13 | 2021-04-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 21,5200 | -811 | -17 | 3.225.558 | ||||
| 2021-04-13 | 2021-04-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,7200 | -1.637 | -34 | 3.226.369 | ||||
| 2021-04-13 | 2021-04-09 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 23,6700 | -10.300 | -244 | 3.228.006 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | -1.534 | 31.002 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | -8.466 | 2.540 | |||||
| 2021-04-05 | 2021-04-01 | 4 | Wesche Holger | HARP | Common Stock | D | 21,1400 | -500 | -11 | 52.852 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Wesche Holger | HARP | Common Stock | D | 20,4127 | -9.500 | -194 | 53.352 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 1.534 | 1 | 62.852 | ||||
| 2021-04-05 | 2021-04-01 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 8.466 | 5 | 61.318 | ||||
| 2021-03-26 | 2021-03-24 | 4 | Colowick Alan | HARP | Director Stock Option (right to buy) | D | 19,63 | 20.335 | 20.335 | |||||
| 2021-02-18 | 2021-02-17 | 4 | Erbez Georgia | HARP | Employee Stock Option (right to buy) | D | 2,12 | -25.000 | 145.908 | |||||
| 2021-02-18 | 2021-02-17 | 4 | Erbez Georgia | HARP | Common Stock | D | 2,1200 | 25.000 | 53 | 72.292 | ||||
| 2021-02-12 | 2021-02-10 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,0000 | -183.051 | -3.661 | 3.238.306 | ||||
| 2021-02-09 | 2021-02-09 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,2500 | -9.400 | -190 | 3.421.357 | ||||
| 2021-02-09 | 2021-02-08 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,0400 | -72.128 | -1.445 | 3.430.757 | ||||
| 2021-02-09 | 2021-02-05 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,0100 | -10.172 | -204 | 3.502.885 | ||||
| 2021-02-04 | 2021-02-04 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,3700 | -29.730 | -606 | 3.513.057 | ||||
| 2021-02-04 | 2021-02-03 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,2100 | -41.922 | -847 | 3.542.787 | ||||
| 2021-02-04 | 2021-02-02 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,1300 | -48.421 | -975 | 3.584.709 | ||||
| 2021-01-29 | 2021-01-28 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 18,66 | 52.000 | 52.000 | |||||
| 2021-01-29 | 2021-01-28 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 18,66 | 80.000 | 80.000 | |||||
| 2021-01-29 | 2021-01-28 | 4 | Erbez Georgia | HARP | Employee Stock Option (right to buy) | D | 18,66 | 72.000 | 72.000 | |||||
| 2021-01-29 | 2021-01-28 | 4 | McMahon Gerald PhD | HARP | Employee Stock Option (right to buy) | D | 18,66 | 181.470 | 181.470 | |||||
| 2021-01-27 | 2021-01-27 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 20,0000 | -706.825 | -14.136 | 3.633.130 | ||||
| 2021-01-27 | 2021-01-26 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 21,0800 | -1.363 | -29 | 4.339.955 | ||||
| 2021-01-27 | 2021-01-25 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 21,2300 | -13.006 | -276 | 4.341.318 | ||||
| 2021-01-22 | 2021-01-22 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 21,7200 | -24.695 | -536 | 4.354.324 | ||||
| 2021-01-22 | 2021-01-21 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 23,7700 | -200 | -5 | 4.379.019 | ||||
| 2021-01-22 | 2021-01-21 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 22,6100 | -4.887 | -110 | 4.379.219 | ||||
| 2021-01-22 | 2021-01-21 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 22,1100 | -20.979 | -464 | 4.384.106 | ||||
| 2021-01-22 | 2021-01-20 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | -101.646 | 4.405.085 | ||||||
| 2021-01-22 | 2021-01-20 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 24,7100 | -2.000 | -49 | 4.506.731 | ||||
| 2021-01-22 | 2021-01-20 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 23,9500 | -15.694 | -376 | 4.508.731 | ||||
| 2021-01-06 | 2021-01-04 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | -10.000 | 11.006 | |||||
| 2021-01-06 | 2021-01-04 | 4 | Wesche Holger | HARP | Common Stock | D | 19,3935 | -3.549 | -69 | 52.852 | ||||
| 2021-01-06 | 2021-01-04 | 4 | Wesche Holger | HARP | Common Stock | D | 18,3010 | -3.351 | -61 | 56.401 | ||||
| 2021-01-06 | 2021-01-04 | 4 | Wesche Holger | HARP | Common Stock | D | 17,3170 | -3.100 | -54 | 59.752 | ||||
| 2021-01-06 | 2021-01-04 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 10.000 | 6 | 62.852 | ||||
| 2020-10-05 | 2020-10-01 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | -10.000 | 21.006 | |||||
| 2020-10-05 | 2020-10-01 | 4 | Wesche Holger | HARP | Common Stock | D | 17,0299 | -1.000 | -17 | 52.669 | ||||
| 2020-10-05 | 2020-10-01 | 4 | Wesche Holger | HARP | Common Stock | D | 16,1897 | -9.000 | -146 | 53.669 | ||||
| 2020-10-05 | 2020-10-01 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 10.000 | 6 | 62.669 | ||||
| 2020-08-20 | 2020-08-19 | 4 | Erbez Georgia | HARP | Common Stock | I | 11,4000 | 5.000 | 57 | 8.915 | ||||
| 2020-08-20 | 2020-08-18 | 4 | Erbez Georgia | HARP | Common Stock | I | 11,6000 | 2.098 | 24 | 3.915 | ||||
| 2020-08-04 | 2020-07-31 | 4 | Erbez Georgia | HARP | Common Stock | I | 10,9200 | 1.817 | 20 | 1.817 | ||||
| 2020-07-02 | 2020-07-01 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | -10.000 | 31.006 | |||||
| 2020-07-02 | 2020-07-01 | 4 | Wesche Holger | HARP | Common Stock | D | 16,1989 | -10.000 | -162 | 52.669 | ||||
| 2020-07-02 | 2020-07-01 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 10.000 | 6 | 62.669 | ||||
| 2020-07-02 | 2020-07-01 | 4 | Viney Joanne L. | HARP | Director Stock Option (right to buy) | D | 17,49 | 20.335 | 20.335 | |||||
| 2020-06-01 | 2020-05-28 | 4 | EASTLAND JULIA MARIE | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 10.167 | 10.167 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Myers Scott Dunseth | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 10.167 | 10.167 | |||||
| 2020-06-01 | 2020-05-28 | 4 | DRACHMAN JONATHAN G | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 2.880 | 2.880 | |||||
| 2020-06-01 | 2020-05-28 | 4 | DRACHMAN JONATHAN G | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 10.167 | 10.167 | |||||
| 2020-06-01 | 2020-05-28 | 4 | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 4.906 | 4.906 | |||||
| 2020-06-01 | 2020-05-28 | 4 | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 10.167 | 10.167 | |||||
| 2020-06-01 | 2020-05-28 | 4 | EVNIN LUKE | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 3.587 | 3.587 | |||||
| 2020-06-01 | 2020-05-28 | 4 | EVNIN LUKE | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 10.167 | 10.167 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Baeuerle Patrick | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 2.584 | 2.584 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Baeuerle Patrick | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 10.167 | 10.167 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 3.017 | 3.017 | |||||
| 2020-06-01 | 2020-05-28 | 4 | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 20,59 | 10.167 | 10.167 | |||||
| 2020-05-29 | 2020-05-28 | 4 | Arix Bioscience plc | HARP | Common stock | I | 21,3342 | -366.591 | -7.821 | 2.193.704 | ||||
| 2020-05-29 | 2020-05-27 | 4 | Arix Bioscience plc | HARP | Common stock | I | 22,3926 | -12.064 | -270 | 2.560.295 | ||||
| 2020-05-20 | 2020-05-18 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -1.522 | 45.625 | |||||
| 2020-05-20 | 2020-05-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 14,7691 | -1.522 | -22 | 45.754 | ||||
| 2020-05-20 | 2020-05-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 1.522 | 3 | 47.276 | ||||
| 2020-05-13 | 2020-05-12 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | -1.400 | 41.006 | |||||
| 2020-05-13 | 2020-05-12 | 4 | Wesche Holger | HARP | Common Stock | D | 14,0857 | -1.400 | -20 | 52.669 | ||||
| 2020-05-13 | 2020-05-12 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 1.400 | 1 | 54.069 | ||||
| 2020-05-11 | 2020-05-11 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | -1.000 | 42.406 | |||||
| 2020-05-11 | 2020-05-11 | 4 | Wesche Holger | HARP | Common Stock | D | 14,0651 | -1.000 | -14 | 52.669 | ||||
| 2020-05-11 | 2020-05-11 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 1.000 | 1 | 53.669 | ||||
| 2020-05-11 | 2020-05-08 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | -1.000 | 43.406 | |||||
| 2020-05-11 | 2020-05-08 | 4 | Wesche Holger | HARP | Common Stock | D | 14,0000 | -1.000 | -14 | 52.669 | ||||
| 2020-05-11 | 2020-05-08 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 1.000 | 1 | 53.669 | ||||
| 2020-05-11 | 2020-05-07 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | -5.350 | 44.406 | |||||
| 2020-05-11 | 2020-05-07 | 4 | Wesche Holger | HARP | Common Stock | D | 14,1263 | -5.350 | -76 | 52.669 | ||||
| 2020-05-11 | 2020-05-07 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 5.350 | 3 | 58.019 | ||||
| 2020-05-05 | 2020-05-01 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -5.826 | 168.926 | |||||
| 2020-05-05 | 2020-05-01 | 4 | Sacks Natalie | HARP | Common Stock | D | 12,0668 | -5.826 | -70 | 45.754 | ||||
| 2020-05-05 | 2020-05-01 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 5.826 | 12 | 51.580 | ||||
| 2020-04-30 | 2020-04-28 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | -1.250 | 49.756 | |||||
| 2020-04-30 | 2020-04-28 | 4 | Wesche Holger | HARP | Common Stock | D | 14,0520 | -1.250 | -18 | 52.669 | ||||
| 2020-04-30 | 2020-04-28 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 1.250 | 1 | 53.919 | ||||
| 2020-04-17 | 2020-04-17 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -1.021 | 47.147 | |||||
| 2020-04-17 | 2020-04-17 | 4 | Sacks Natalie | HARP | Common Stock | D | 12,0765 | -1.021 | -12 | 45.754 | ||||
| 2020-04-17 | 2020-04-17 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 1.021 | 2 | 46.775 | ||||
| 2020-04-17 | 2020-04-16 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -500 | 48.168 | |||||
| 2020-04-17 | 2020-04-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 12,0000 | -500 | -6 | 45.754 | ||||
| 2020-04-17 | 2020-04-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 500 | 1 | 46.254 | ||||
| 2020-04-15 | 2020-04-13 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -4.556 | 174.752 | |||||
| 2020-04-15 | 2020-04-13 | 4 | Sacks Natalie | HARP | Common Stock | D | 12,0630 | -4.556 | -55 | 45.754 | ||||
| 2020-04-15 | 2020-04-13 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 4.556 | 10 | 50.310 | ||||
| 2020-04-08 | 2020-04-07 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -570 | 179.308 | |||||
| 2020-04-08 | 2020-04-07 | 4 | Sacks Natalie | HARP | Common Stock | D | 12,0000 | -570 | -7 | 45.754 | ||||
| 2020-04-08 | 2020-04-07 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 570 | 1 | 46.324 | ||||
| 2020-04-08 | 2020-04-06 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -700 | 179.878 | |||||
| 2020-04-08 | 2020-04-06 | 4 | Sacks Natalie | HARP | Common Stock | D | 12,0014 | -700 | -8 | 45.754 | ||||
| 2020-04-08 | 2020-04-06 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 700 | 1 | 46.454 | ||||
| 2020-04-01 | 2020-03-30 | 4 | Robbins Andrew R | HARP | Director Stock Option (right to buy) | D | 11,78 | 20.335 | 20.335 | |||||
| 2020-04-01 | 2020-03-30 | 4 | BAILES JOSEPH S | HARP | Director Stock Option (right to buy) | D | 11,78 | 20.335 | 20.335 | |||||
| 2020-03-18 | 2020-03-17 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -1.520 | 48.668 | |||||
| 2020-03-18 | 2020-03-17 | 4 | Sacks Natalie | HARP | Common Stock | D | 12,0000 | -1.520 | -18 | 45.754 | ||||
| 2020-03-18 | 2020-03-17 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 1.520 | 3 | 47.274 | ||||
| 2020-03-18 | 2020-03-16 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -1 | 50.188 | |||||
| 2020-03-18 | 2020-03-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 12,0000 | -1 | -0 | 45.754 | ||||
| 2020-03-18 | 2020-03-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 1 | 0 | 45.755 | ||||
| 2020-03-03 | 2020-03-02 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -5.826 | 180.578 | |||||
| 2020-03-03 | 2020-03-02 | 4 | Sacks Natalie | HARP | Common Stock | D | 14,6800 | -5.826 | -86 | 45.754 | ||||
| 2020-03-03 | 2020-03-02 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 5.826 | 12 | 51.580 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -1.521 | 50.189 | |||||
| 2020-02-20 | 2020-02-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 15,0000 | -1.521 | -23 | 45.754 | ||||
| 2020-02-20 | 2020-02-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 1.521 | 3 | 47.275 | ||||
| 2020-02-04 | 2020-01-31 | 4 | McMahon Gerald PhD | HARP | Employee Stock Option (right to buy) | D | 13,29 | 165.210 | 165.210 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Erbez Georgia | HARP | Employee Stock Option (right to buy) | D | 13,29 | 52.160 | 52.160 | |||||
| 2020-02-04 | 2020-02-03 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -5.826 | 186.404 | |||||
| 2020-02-04 | 2020-02-03 | 4 | Sacks Natalie | HARP | Common Stock | D | 13,9043 | -5.826 | -81 | 45.754 | ||||
| 2020-02-04 | 2020-02-03 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 5.826 | 12 | 51.580 | ||||
| 2020-02-04 | 2020-01-31 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 13,29 | 75.440 | 75.440 | |||||
| 2020-02-04 | 2020-01-31 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 13,29 | 52.313 | 52.313 | |||||
| 2020-01-23 | 2020-01-21 | 4 | Erbez Georgia | HARP | Common Stock | I | 14,0922 | 6.700 | 94 | 6.700 | ||||
| 2020-01-21 | 2020-01-16 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -1.521 | 51.710 | |||||
| 2020-01-21 | 2020-01-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 14,9408 | -1.521 | -23 | 45.754 | ||||
| 2020-01-21 | 2020-01-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 1.521 | 3 | 47.275 | ||||
| 2020-01-06 | 2020-01-02 | 4 | Wesche Holger | HARP | Employee Stock Option (right to buy) | D | 0,60 | -10.000 | 51.006 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Wesche Holger | HARP | Common Stock | D | 14,3987 | -10.000 | -144 | 52.669 | ||||
| 2020-01-06 | 2020-01-02 | 4 | Wesche Holger | HARP | Common Stock | D | 0,6000 | 10.000 | 6 | 62.669 | ||||
| 2020-01-06 | 2020-01-02 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -5.826 | 192.230 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Sacks Natalie | HARP | Common Stock | D | 14,1779 | -5.826 | -83 | 45.754 | ||||
| 2020-01-06 | 2020-01-02 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 5.826 | 12 | 51.580 | ||||
| 2019-12-30 | 2019-12-27 | 4 | Baeuerle Patrick | HARP | Common Stock | I | 18,0690 | -1.400 | -25 | 262.136 | ||||
| 2019-12-30 | 2019-12-27 | 4 | Baeuerle Patrick | HARP | Common Stock | I | 16,9014 | -10.417 | -176 | 263.536 | ||||
| 2019-12-30 | 2019-12-27 | 4 | Baeuerle Patrick | HARP | Common Stock | I | 15,8138 | -75.562 | -1.195 | 273.953 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -1.521 | 53.231 | |||||
| 2019-12-18 | 2019-12-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 17,0201 | -1.521 | -26 | 45.754 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 1.521 | 3 | 47.275 | ||||
| 2019-12-17 | 2019-12-17 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 16,8298 | -12.476 | -210 | 2.572.359 | ||||
| 2019-12-17 | 2019-12-16 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 17,0245 | -13.080 | -223 | 2.584.835 | ||||
| 2019-12-17 | 2019-12-13 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 17,2097 | -11.002 | -189 | 2.597.915 | ||||
| 2019-12-17 | 2019-12-17 | 4 | Arix Bioscience plc | HARP | Common stock | I | 16,8298 | -12.476 | -210 | 2.572.359 | ||||
| 2019-12-17 | 2019-12-16 | 4 | Arix Bioscience plc | HARP | Common stock | I | 17,0245 | -13.080 | -223 | 2.584.835 | ||||
| 2019-12-17 | 2019-12-13 | 4 | Arix Bioscience plc | HARP | Common stock | I | 17,2097 | -11.002 | -189 | 2.597.915 | ||||
| 2019-12-10 | 2019-12-10 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 16,9103 | -131.696 | -2.227 | 2.608.917 | ||||
| 2019-12-10 | 2019-12-09 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 18,1161 | -77.316 | -1.401 | 2.740.613 | ||||
| 2019-12-10 | 2019-12-09 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 18,2987 | -26.438 | -484 | 2.817.929 | ||||
| 2019-12-10 | 2019-12-06 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 19,1452 | -47.752 | -914 | 2.844.367 | ||||
| 2019-12-10 | 2019-12-10 | 4 | Arix Bioscience plc | HARP | Common stock | I | 16,9103 | -131.696 | -2.227 | 2.608.917 | ||||
| 2019-12-10 | 2019-12-09 | 4 | Arix Bioscience plc | HARP | Common stock | I | 18,1161 | -77.316 | -1.401 | 2.740.613 | ||||
| 2019-12-10 | 2019-12-09 | 4 | Arix Bioscience plc | HARP | Common stock | I | 18,2987 | -26.438 | -484 | 2.817.929 | ||||
| 2019-12-10 | 2019-12-06 | 4 | Arix Bioscience plc | HARP | Common stock | I | 19,1452 | -47.752 | -914 | 2.844.367 | ||||
| 2019-12-06 | 2019-12-04 | 4 | Erbez Georgia | HARP | Employee Stock Option (right to buy) | D | 2,12 | -47.292 | 170.908 | |||||
| 2019-12-06 | 2019-12-04 | 4 | Erbez Georgia | HARP | Common Stock | D | 2,1200 | 47.292 | 100 | 47.292 | ||||
| 2019-12-04 | 2019-12-02 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -5.826 | 198.056 | |||||
| 2019-12-04 | 2019-12-02 | 4 | Sacks Natalie | HARP | Common Stock | D | 17,9800 | -5.826 | -105 | 45.754 | ||||
| 2019-12-04 | 2019-12-02 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 5.826 | 12 | 51.580 | ||||
| 2019-11-19 | 2019-11-18 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -18.252 | 54.752 | |||||
| 2019-11-19 | 2019-11-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 14,0000 | -1.000 | -14 | 45.754 | ||||
| 2019-11-19 | 2019-11-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 13,3297 | -17.252 | -230 | 46.754 | ||||
| 2019-11-19 | 2019-11-18 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 18.252 | 39 | 64.006 | ||||
| 2019-11-05 | 2019-11-01 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -5.826 | 203.882 | |||||
| 2019-11-05 | 2019-11-01 | 4 | Sacks Natalie | HARP | Common Stock | D | 13,1654 | -5.826 | -77 | 45.754 | ||||
| 2019-11-05 | 2019-11-01 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 5.826 | 12 | 51.580 | ||||
| 2019-10-16 | 2019-10-15 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -11.698 | 209.708 | |||||
| 2019-10-16 | 2019-10-15 | 4 | Sacks Natalie | HARP | Common Stock | D | 13,2058 | -11.698 | -154 | 45.754 | ||||
| 2019-10-16 | 2019-10-15 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 11.698 | 25 | 57.452 | ||||
| 2019-10-16 | 2019-10-14 | 4 | Sacks Natalie | HARP | Employee Stock Option (right to buy) | D | 2,12 | -12.452 | 221.406 | |||||
| 2019-10-16 | 2019-10-14 | 4 | Sacks Natalie | HARP | Common Stock | D | 13,2734 | -12.452 | -165 | 45.754 | ||||
| 2019-10-16 | 2019-10-14 | 4 | Sacks Natalie | HARP | Common Stock | D | 2,1200 | 12.452 | 26 | 58.206 | ||||
| 2019-09-06 | 2019-06-05 | 4 | McMahon Gerald PhD | HARP | Employee Stock Option (right to buy) | D | 0,60 | -169.462 | 318.590 | |||||
| 2019-09-06 | 2019-06-05 | 4 | McMahon Gerald PhD | HARP | Common Stock | D | 0,6000 | 169.462 | 102 | 172.462 | ||||
| 2019-06-05 | 2019-06-03 | 4 | DRACHMAN JONATHAN G | HARP | Director Stock Option (Right to Buy) | D | 11,84 | 10.167 | 10.167 | |||||
| 2019-06-05 | 2019-06-03 | 4 | EASTLAND JULIA MARIE | HARP | Director Stock Option (Right to Buy) | D | 11,84 | 10.167 | 10.167 | |||||
| 2019-06-05 | 2019-06-03 | 4 | EVNIN LUKE | HARP | Director Stock Option (Right to Buy) | D | 11,84 | 10.167 | 10.167 | |||||
| 2019-06-05 | 2019-06-03 | 4 | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 11,84 | 10.167 | 10.167 | |||||
| 2019-06-05 | 2019-06-03 | 4 | Myers Scott Dunseth | HARP | Director Stock Option (Right to Buy) | D | 11,84 | 10.167 | 10.167 | |||||
| 2019-06-05 | 2019-06-03 | 4 | Baeuerle Patrick | HARP | Director Stock Option (Right to Buy) | D | 11,84 | 10.167 | 10.167 | |||||
| 2019-06-05 | 2019-06-03 | 4 | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 11,84 | 10.167 | 10.167 | |||||
| 2019-05-16 | 2019-05-14 | 4 | McMahon Gerald PhD | HARP | Common Stock | D | 10,1573 | 1.000 | 10 | 3.000 | ||||
| 2019-05-10 | 2019-05-08 | 4 | McMahon Gerald PhD | HARP | Common Stock | D | 10,5587 | 1.000 | 11 | 2.000 | ||||
| 2019-05-07 | 2019-05-03 | 4 | McMahon Gerald PhD | HARP | Common Stock | D | 10,5300 | 1.000 | 11 | 1.000 | ||||
| 2019-03-29 | 2019-02-07 | 4/A | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 14,00 | 6.071 | 6.071 | |||||
| 2019-03-29 | 2019-02-07 | 4/A | EVNIN LUKE | HARP | Director Stock Option (Right to Buy) | D | 14,00 | 7.658 | 7.658 | |||||
| 2019-03-29 | 2019-02-07 | 4/A | HUNT RONALD | HARP | Director Stock Option (Right to Buy) | D | 14,00 | 4.923 | 4.923 | |||||
| 2019-03-29 | 2019-02-07 | 4 | DRACHMAN JONATHAN G | HARP | Director Stock Option (Right to Buy) | D | 14,00 | 4.266 | 4.266 | |||||
| 2019-03-29 | 2019-02-07 | 4 | EASTLAND JULIA MARIE | HARP | Director Stock Option (Right to Buy) | D | 14,00 | 5.907 | 5.907 | |||||
| 2019-03-29 | 2019-02-07 | 4 | Baeuerle Patrick | HARP | Director Stock Option (Right to Buy) | D | 14,00 | 3.829 | 3.829 | |||||
| 2019-02-14 | 2019-02-12 | 4 | Arix Bioscience plc | HARP | Series C Convertible Preferred Stock | I | -742.850 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Arix Bioscience plc | HARP | Series B Convertible Preferred Stock | I | -1.720.698 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Arix Bioscience plc | HARP | Common stock | I | 14,0000 | 428.571 | 6.000 | 2.892.119 | ||||
| 2019-02-14 | 2019-02-12 | 4 | Arix Bioscience plc | HARP | Common stock | I | 2.463.548 | 2.463.548 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | -50.837 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | -50.837 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | -76.256 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | -171.579 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | -57.192 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | -25.418 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Series C Preferred Stock | I | -417.852 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Series B Preferred Stock | I | -1.578.751 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Series A Preferred Stock | I | -1.525.164 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock | I | 14,0000 | 250.000 | 3.500 | 4.524.425 | ||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock | I | 14,0000 | -1.524 | -21 | 4.274.425 | ||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock | I | 0,0492 | 432.119 | 21 | 4.275.949 | ||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock | I | 417.852 | 3.843.830 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock | I | 1.578.751 | 3.425.978 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | EVNIN LUKE | HARP | Common Stock | I | 1.525.164 | 1.847.227 | ||||||
| 2019-02-14 | 2018-12-19 | 4 | EVNIN LUKE | HARP | Director Stock Option (Right to Buy) | D | 2,12 | 20.335 | 20.335 | |||||
| 2019-02-14 | 2018-11-09 | 4 | EVNIN LUKE | HARP | Series C Preferred Stock | I | 417.852 | 417.852 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Series C Preferred Stock | I | -742.850 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Series B Preferred Stock | I | -1.720.698 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 14,0000 | 428.571 | 6.000 | 2.892.119 | ||||
| 2019-02-14 | 2019-02-12 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 742.850 | 2.463.548 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Common Stock | I | 1.720.698 | 1.720.698 | ||||||
| 2019-02-14 | 2018-12-19 | 4 | Chin Mark | HARP | Director Stock Option (Right to Buy) | D | 2,12 | 20.335 | 20.335 | |||||
| 2019-02-14 | 2018-11-09 | 4 | Chin Mark By Arix Bioscience Holdings Limited | HARP | Series C Preferred Stock | I | 742.850 | 742.850 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | -101.675 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | -152.514 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | -50.837 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | -171.579 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | -57.192 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | -25.418 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Series C Preferred Stock | I | -835.705 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Series B Preferred Stock | I | -3.157.506 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Series A Preferred Stock | I | -3.050.329 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 14,0000 | 500.000 | 7.000 | 8.422.847 | ||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 14,0000 | -1.971 | -28 | 7.922.847 | ||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 0,0492 | 559.215 | 28 | 7.924.818 | ||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 835.705 | 7.365.603 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 3.157.506 | 6.529.898 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | GADICKE ANSBERT | HARP | Common Stock | I | 3.050.329 | 3.372.392 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Series C Convertible Preferred Stock | I | -464.281 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Series C Convertible Preferred Stock | I | -464.281 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Series B Convertible Preferred Stock | I | -1.564.272 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Common Stock | I | 14,0000 | 214.285 | 3.000 | 678.566 | ||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Common Stock | I | 14,0000 | 214.286 | 3.000 | 2.242.839 | ||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Common Stock | I | 464.281 | 464.281 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Common Stock | I | 464.281 | 464.281 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | HUNT RONALD | HARP | Common Stock | I | 1.564.272 | 1.564.272 | ||||||
| 2019-02-14 | 2018-12-19 | 4 | HUNT RONALD | HARP | Director Stock Option (right to buy) | D | 2,12 | 20.335 | 20.335 | |||||
| 2019-02-14 | 2018-11-09 | 4 | HUNT RONALD | HARP | Series C Convertible Preferred Stock | I | 464.281 | 464.281 | ||||||
| 2019-02-14 | 2018-11-09 | 4 | HUNT RONALD | HARP | Series C Convertible Preferred Stock | I | 464.281 | 464.281 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | -50.837 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | -50.837 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | -76.256 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | -171.579 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | -57.192 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock Warrant (Right to Buy) | I | 0,05 | -25.418 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Series C Preferred Stock | I | -417.852 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Series B Preferred Stock | I | -1.578.751 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Series A Preferred Stock | I | -1.525.164 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 14,0000 | 250.000 | 3.500 | 4.524.425 | ||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 14,0000 | -1.524 | -21 | 4.274.425 | ||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 0,0492 | 432.119 | 21 | 4.275.949 | ||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 417.852 | 3.843.830 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 1.578.751 | 3.425.978 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | MPM BioVentures 2014, L.P. | HARP | Common Stock | I | 1.525.164 | 1.847.227 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Series C Convertible Preferred Stock | I | -464.281 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Series C Convertible Preferred Stock | I | -464.281 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Series B Convertible Preferred Stock | I | -1.564.272 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Common Stock | I | 14,0000 | 214.285 | 3.000 | 678.566 | ||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Common Stock | I | 14,0000 | 214.286 | 3.000 | 2.242.839 | ||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Common Stock | I | 464.281 | 464.281 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Common Stock | I | 464.281 | 464.281 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | New Leaf Ventures III, L.P. | HARP | Common Stock | I | 1.564.272 | 1.564.272 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock Warrant (Right to Buy) | D | 0,05 | -50.838 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock Warrant (Right to Buy) | D | 0,05 | -76.258 | 0 | |||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Series C Preferred Stock | D | -417.853 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Series B Preferred Stock | D | -1.578.755 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Series A Preferred Stock | D | -1.525.165 | 0 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock | D | 14,0000 | 250.000 | 3.500 | 3.898.422 | ||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock | D | 14,0000 | -447 | -6 | 3.648.422 | ||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock | D | 0,0492 | 127.096 | 6 | 3.648.869 | ||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock | D | 417.853 | 3.521.773 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock | D | 1.578.755 | 3.103.920 | ||||||
| 2019-02-14 | 2019-02-12 | 4 | UBS Oncology Impact Fund L.P. | HARP | Common Stock | D | 1.525.165 | 1.525.165 | ||||||
| 2019-02-07 | 3 | Myers Scott Dunseth | HARP | Common Stock | D | 55.312 | ||||||||
| 2019-02-07 | 3 | Myers Scott Dunseth | HARP | Common Stock | D | 55.312 | ||||||||
| 2019-02-07 | 3 | Myers Scott Dunseth | HARP | Common Stock | D | 55.312 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644.126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644.126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644.126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644.126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644.126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644.126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644.126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644.126 | ||||||||
| 2019-02-07 | 3 | MPM ASSET MANAGEMENT LLC | HARP | Common Stock | I | 644.126 | ||||||||
| 2019-02-07 | 3 | GADICKE ANSBERT | HARP | Common Stock | I | 644.126 | ||||||||
| 2019-02-07 | 3 | GADICKE ANSBERT | HARP | Common Stock | I | 644.126 | ||||||||
| 2019-02-07 | 3 | GADICKE ANSBERT | HARP | Common Stock | I | 644.126 | ||||||||
| 2019-02-07 | 3 | Baeuerle Patrick | HARP | Common Stock | I | 699.030 | ||||||||
| 2019-02-07 | 3 | Baeuerle Patrick | HARP | Common Stock | I | 699.030 | ||||||||
| 2019-02-07 | 3 | Baeuerle Patrick | HARP | Common Stock | I | 699.030 | ||||||||
| 2019-02-07 | 3 | EVNIN LUKE | HARP | Common Stock | I | 644.126 | ||||||||
| 2019-02-07 | 3 | EVNIN LUKE | HARP | Common Stock | I | 644.126 | ||||||||
| 2019-02-07 | 3 | EVNIN LUKE | HARP | Common Stock | I | 644.126 | ||||||||
| 2019-02-07 | 3 | Sacks Natalie | HARP | Common Stock | D | 91.508 | ||||||||
| 2019-02-07 | 3 | Sacks Natalie | HARP | Common Stock | D | 91.508 | ||||||||
| 2019-02-07 | 3 | Sacks Natalie | HARP | Common Stock | D | 91.508 | ||||||||
| 2019-02-07 | 3 | Wesche Holger | HARP | Common Stock | D | 105.338 | ||||||||
| 2019-02-07 | 3 | Wesche Holger | HARP | Common Stock | D | 105.338 | ||||||||
| 2019-02-07 | 3 | Wesche Holger | HARP | Common Stock | D | 105.338 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
